The results revealed that the OS of glioma patients with increased Siglec15 expression levels was unfavorable according to Kaplan−Meier survival analysis of TCGA database (P < 0.001) and CGGA database (P < 0.001) (Figure 2C). Here, SIGLEC15 is linked to central nervous system cancer.